Inventor · disambiguated record
Lawrence Wilson
Also filed as: WILSON LAWRENCE · WILSON LAWRENCE J · WILSON LAWRENCE JOSEPH
16 granted patents·7 pending applications·59 citations·filing 1992–2024
91Inventor score
Top patents by PatentIndex Score
23 records- 0192US9545403B2Chemokine CXCR4 receptor modulators and uses related theretoUNIV EMORY·Filed 2015·Granted Jan 17, 2017·6 cites·12 claims
- 0290US9314468B2Chemokine receptor modulatorsALTIRIS THERAPEUTICS INC·Filed 2012·Granted Apr 19, 2016·21 cites·8 claims
- 0388US8969381B2Chemokine CXCR4 receptor modulators and used related theretoWILSON LAWRENCE J·Filed 2011·Granted Mar 3, 2015·9 cites·13 claims
- 0486US10016408B2Chemokine CXCR4 receptor modulators and uses related theretoUNIV EMORY·Filed 2016·Granted Jul 10, 2018·4 cites·6 claims
- 0579US12415790B2GluN2B-subunit selective antagonists of the N-methyl-D-aspartate receptors with enhanced potency at acidic pHUNIV EMORY·Filed 2024·Granted Sep 16, 2025·0 cites·20 claims
- 0679US8338448B2Chemokine receptor modulatorsCLARK MICHAEL P·Filed 2009·Granted Dec 25, 2012·5 cites·11 claims
- 0779US7803793B2Heterocyclic derived metalloprotease inhibitorsJANSSEN PHARMACEUTICA NV·Filed 2007·Granted Sep 28, 2010·5 cites·32 claims
- 0878US8420680B2NMDA receptor antagonists for neuroprotectionLIOTTA DENNIS C·Filed 2008·Granted Apr 16, 2013·5 cites·26 claims
- 0972US11649235B2Pan-tropic entry inhibitorsUNIV EMORY·Filed 2019·Granted May 16, 2023·1 cites·12 claims
- 1071US9079852B2NMDA receptor antagonists for neuroprotectionLIOTTA DENNIS C·Filed 2013·Granted Jul 14, 2015·2 cites·23 claims
- 1170US11497744B2Chemokine CXCR4 receptor modulators and uses related theretoUNIV EMORY·Filed 2018·Granted Nov 15, 2022·1 cites·21 claims
- 1269US12286434B2Pan-tropic entry inhibitorsUNIV EMORY·Filed 2023·Granted Apr 29, 2025·0 cites·18 claims
- 1367US2023112832A1Chemokine CXCR4 Receptor Modulators and Uses Related TheretoUNIV EMORY·Filed 2022·Application pending·0 cites
- 1465US2024360091A1Glun2b-subunit selective antagonists of the n-methyl-d-aspartate receptors with enhanced potency at acidic phUNIV EMORY·Filed 2022·Application pending·0 cites
- 1556US2024368146A1Morpholine-Containing & Piperazine-Containing CXCR4 Modulators and Uses Related TheretoUNIV EMORY·Filed 2022·Application pending·0 cites
- 1645US2008085893A1Matrix metalloprotease inhibitorsYANG SHYH-MING·Filed 2007·Application pending·0 cites
- 1739US2007249590A1Substituted indolo[2,3-a]pyrrolo[3,4-c]carbazole compounds useful in treating kinase disordersWILSON LAWRENCE J·Filed 2006·Application pending·0 cites
- 1836US2002002286A1Solid-phase process for making indole compoundsFiled 2001·Application pending·0 cites
- 1934US2010279986A1Heterocyclic derived metalloprotease inhibitorsZHANG YUE-MEI·Filed 2010·Application pending·0 cites
- 2030US6420556B1Acyl isothiocyanate resins and their use in solid-supported synthesis of guanidinesPROCTER & GAMBLE·Filed 1999·Granted Jul 16, 2002·0 cites·8 claims
- 2130US6413785B1Solid phase synthesis of 1-aminohydantoinsPROCTER & GAMBLE·Filed 1999·Granted Jul 2, 2002·0 cites·16 claims
- 2229US10450293B2Chemokine CXCR4 and CCR5 receptor modulators and uses related theretoUNIV EMORY·Filed 2015·Granted Oct 22, 2019·0 cites·8 claims
- 2329US5602245AOne vessel stereoselective glycosylation of purines and pyrimidinesUNIV EMORY·Filed 1992·Granted Feb 11, 1997·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Lawrence Wilson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →